Pregnancy and rheumatoid arthritis

Indian Journal of Medical Sciences

Volumn 60, Issue 8, 2006, Pages 334-344

  Tandon, Vishal ^a,b   Sharma, Sudhaa ^a   Mahajan, Annil ^a   Khajuria, Vijay ^a   Kumar, Ajay ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

(Physiopathology or physiology); Humans; Pregnancy; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; AZATHIOPRINE; BETAMETHASONE; COLESTYRAMINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD DERIVATIVE; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PENICILLAMINE; PREDNISONE; PROSTAGLANDIN SYNTHASE INHIBITOR; SALAZOSULFAPYRIDINE;

ABORTION; ANENCEPHALUS; ARTERY MALFORMATION; BLEEDING; BONE MARROW TOXICITY; CELLULAR IMMUNITY; CLEFT LIP; CLEFT PALATE; CRANIOFACIAL MALFORMATION; DISEASE ACTIVITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; FEMALE; FEMALE FERTILITY; FETUS DEATH; FETUS DISEASE; FETUS MALFORMATION; HUMAN; HUMORAL IMMUNITY; HYDROCEPHALUS; INTRAUTERINE GROWTH RETARDATION; KERNICTERUS; KIDNEY DYSFUNCTION; LABOR COMPLICATION; LIMB DEFECT; LOW DRUG DOSE; MATERNAL MORBIDITY; OLIGOHYDRAMNIOS; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE CLOSURE OF DUCTUS ARTERIOSUS; PREMATURITY; PROLONGED LABOR; PULMONARY HYPERTENSION; REMISSION; RENOVASCULAR DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SPONTANEOUS ABORTION; TERATOGENICITY; UTERUS CONTRACTILITY INHIBITION; UTERUS DISEASE;

EID: 33746885495     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.26612     Document Type: Review

References (53)

1. rd ed. Oxford University Press: United States; 2004. p. 117-25.
2. Ostensen M. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis and juvenile rheumatoid arthritis. Am J Reprod Immunol 1992;28:235-7.
3. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005;294:2751-7.
4. Pietschmann P. Sex differences in joint diseases: Pathophysiological basis. Wien Med Wochenschr 2001;151:573-5.
5. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 1996;41:156-65.
6. Pura M, Kreze A Jr. From the history of endocrinology: Reminiscence of the discovery of adrenocortical hormones. Cas Lek Cesk 2005;144:648-50; discussion 650-1.
7. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997;23:195-212.
8. Ostensen M, Fuhrer L, Mathieu R, Seitz M, Villiger PM. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 2004;63:1212-7.
9. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999;42:1219-27.
10. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992; 35:152-5.
11. Ostensen M, Forger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005; 64:839-44.
12. Barrett JH, Brennan P, Fiddler M, Silman A. Breastfeeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000;43:1010-5.
13. Drossaers-Bakker KW, Zwinderman AH, van Zeben D, Breedveld FC, Hazes JM. Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis 2002;61:405-8.
14. Soldin OP, Guo T, Weiderpass E, Tractenberg RE, Hilakivi-Clarke L, Soldin SJ. Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil Steril 2005;84:701-10.
15. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci 1999;876:131-43.
16. Neeck G. Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis. Ann N Y Acad Sci 2002;966:28-38.
17. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the Skelton. Mol Endocrinol 1999;13:819-28.
18. Canellada A, Blois S, Gentile T, Margni Idehu RA. In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am J Reprod Immunol 2002;48:334-43.
19. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002;21:471-95.
20. Kanik KS, Wilder RL. Hormonal alterations in RA, including the effects of pregnancy. Rheumatic Disease Clinics of North America 2000;26:805-23.
21. Munoz-Valle JF, Vazquez-Del Mercado M, Garcia-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martinez-Bonilla G, et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 2003;131:377-84.
22. Skornicka EL, Kiyatkina N, Weber MC, Tykocinski ML, Koo PH. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. Cell Immunol 2004;232:144-56.
23. Flaminio MJ, Antczak DF. Inhibition of lymphocyte proliferation and activation: A mechanism used by equine invasive trophoblast to escape the maternal immune response. Placenta 2005;26:148-59.
24. Gonzalez DA, de Leon AC, Moncholi CV, Cordova Jde C, Hernandez LB. Arthritis in mice: Allogeneic pregnancy protects more than syngeneic by attenuating cellular immune response. J Rheumatol 2004;31:30-4.
25. Alavi A, Arden N, Spector TD, Axford JS. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 2000;27:1379-85.
26. Gentile T, Llambias P, Dokmetjian J, Margni RA. Effect of pregnancy and placental factors on the quality of humoral immune response. Immunol Lett 1998;62:151-7.
27. Crocker IP, Lawson N, Baker PN, Fletcher J. The anti-inflammatory effects of circulating fatty acids in obstructive jaundice: Similarities with pregnancyinduced immunosuppression. QJM 2001;94:475-84.
28. Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993;329:466-71.
29. Matera L, Mori M, Geuna M, Buttiglieri S, Palestro G. Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 2000;109:47-55.
30. Weber T. Pregnancy, labor and puerperium in connection with rheumatoid arthritis. Ugeskr Laeger 2003;165:3075.
31. Nelson JL, Voigt LF, Koepsell TD, Dugowson CE, Daling JR. Pregnancy outcome in women with rheumatoid arthritis before disease onset. J Rheumatol 1992;19:18-21.
32. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:899-907
33. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Connective tissue disorders. In: Cunningham FG, Gant NF, Leveno KJ et al (editors) Williams Obstetrics. 21st ed. McGraw Hill: 2003. p. 1394-9.
34. McHugh NJ, Reilly PA, McHugh LA. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 1989;16:42-6.
35. Siamopoulou-Mavridou A, Manoussakis MN, Mavridis AK, Moutsopoulos HM. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 1988;47:982-7.
36. Silman AJ. Parity status and the development of rheumatoid arthritis. Am J Reprod Immunol 1992;28:228-30.
37. Da Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992;11:189-94.
38. Barron WM, Lindheimer MD, Davison JM. Rheumatoid arthritis: Definition and Clinical Course. In: Barron WM, Lindheimer MD, Davison JM (editors), Medical Disorders During Pregnancy. 3rd ed. Mosby Inc: New Delhi; 2000. p. 374-5.
39. Hazes JM, deMan YA. Antirheumatic drugs in pregnancy and lactation. In: (editors) Isenberg DA, Maddison PJ, Woo P,Glass D, Breedveld FC. Oxford textbook of rheumatology. 3rd ed. Oxford University Press: United States; 2004. p. 126-33.
40. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35:112-21.
41. Ostensen ME, Skomsvoll JF. Anti-inflammatory pharmacotherapy during pregnancy. Exp Opin Pharmacother 2004;5:571-80.
42. Florescu A, Koren G. Nonsteroidal antiinflammatory drugs for rheumatoid arthritis during pregnancy. Can Fam Physician 2005;51:961-2.
43. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999;86:242-4.
44. Coe CL, Lubach GR. Developmental consequences of antenatal dexamethasone treatment in nonhuman primates. Neurosci Biobehav Rev 2005;29:227-35.
45. Costedoat-Chalumeau N, Amoura Z, Aymard G, Le TH, Wechsler B, Vauthier D, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002;46:1123-4.
46. Mogadam M, Dobbins WO 3rd, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80:72-6.
47. Lee P. Anti-inflammatory therapy during pregnancy and lactation. Clin Invest Med 1985;8:328-32.
48. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J Rheumatol 2003;30:241-6.
49. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209
50. Kozer E, Moretti ME, Koren G. Leflunomide: New antirheumatic drug. Effect on pregnancy outcomes. Can Fam Physician 2001;47:721-2.
51. Shrim A, Koren G. Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy. Can Fam Physician 2005;51:667-8.
52. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-92.
53. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception and normal delivery after chronic therapy with etanercept: A recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001;46:366-8.